The Food and Drug Administration (FDA) has granted Fast Track designation to 4P004, an intra-articularly administered glucagon-like peptide-1 receptor agonist (GLP-1RA), for the treatment of knee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results